Why NHS Innovation Stalls
Why It Matters
Stalled NHS innovation curtails patient outcomes and wastes potential cost savings; aligning evidence, platform design, and supportive policy can unlock transformative health improvements across the UK.
Key Takeaways
- •Evidence and cost savings are non-negotiable for NHS adoption.
- •Platform-scale solutions outperform vertical pilots in complex NHS environment.
- •Securing three champions—clinical, operational, economic—is essential for successful scaling.
- •Regulatory uncertainty and process rigidity hinder innovation scaling.
- •Resilience and leveraging systemic pressure drive successful NHS innovation.
Summary
The Digital Health Unplugged episode examines why innovation stalls in the NHS, featuring Mindy Simon of the NHS Innovation Accelerator and Alina Nenova, CEO of Feebris, to unpack scaling challenges and systemic lessons.
They stress that robust evidence of cost‑effectiveness and patient benefit is mandatory; the NHS prefers platform‑wide solutions over niche pilots, and the effort to pilot equals that of scaling, demanding realistic resource planning. They also note the need for three internal champions—clinical, operational, economic—to navigate the system.
Simon warns many innovators lack tangible productivity gains, while Nenova highlights that first‑mover advantage is weak; trust and evidence built over years matter. A notable quote: “Pressure is probably the biggest enabler of change in the NHS,” reflecting how crises accelerate adoption.
The implications are clear: startups must design scalable platforms, secure multi‑disciplinary advocacy, and tolerate long procurement cycles. Policymakers should streamline regulations and funding pathways to prevent bureaucratic roadblocks, ensuring that proven innovations reach patients efficiently.
Comments
Want to join the conversation?
Loading comments...